<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00925444</url>
  </required_header>
  <id_info>
    <org_study_id>P080204</org_study_id>
    <secondary_id>IDRCB 2008-A01386-49</secondary_id>
    <nct_id>NCT00925444</nct_id>
  </id_info>
  <brief_title>Staple-line Reinforcement for Prevention of Pulmonary Air Leakage</brief_title>
  <acronym>SPIRAL</acronym>
  <official_title>Medical and Economic Evaluation of FORESEAL Versus the Current Therapeutic Approach (Stapling Alone or Associated With Tissue Sealant) in Terms of Air Leakage Duration After Lung Resection for Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the efficacy of FORESEAL with stapling alone or
      associated with tissue sealant or glue in terms of air leakage duration after lung resection
      for cancer.

      Hypothesis: to show a significant difference of 1 day in the average duration of air leakage
      between the 2 groups with a standard deviation of 3 (α =0.05 and β=0.10).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Air leaks continue to be the most common complication after pulmonary resection even using a
      stapling device. Double chest tubes after lobectomy is a well established method for drainage
      of the pleural cavity to allow adequate expansion of the remaining lung.

      FORESEAL has been developed to reduce air leaks by buttressing the staple line. It is a
      absorbable vegetal biopolymer in the form of sleeves, CE marked and indicated for prevention
      of air leakage after pulmonary resection with stapling device. It acts as a suture
      reinforcement as well as a sealant thanks to its jellification.

      Sealants are also commonly used in addition to stapling to prevent air leakage. The aim of
      this study is to compare the efficacy of FORESEAL with stapling alone or associated with
      sealants.

      This is a multi centre, prospective controlled and randomised clinical study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Air leak (presence or absence of bubbles) will be assessed from T0: one hour after extubation, and then twice daily (morning and evening). The mean duration of post-operative air leakage will be calculated from T0 to the last day air leak observed.</measure>
    <time_frame>from T0 to the last day air leak observed</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of patients presenting prolonged air leakage (lasting more than 5 days). Average duration of drainage Incidence of patients without any air leakage at 24 hours after surgery Post-operative complications Nature and costs of treatments</measure>
    <time_frame>withing the first one year after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">380</enrollment>
  <condition>Lung Neoplasms</condition>
  <condition>Pulmonary Surgical Procedures</condition>
  <condition>Surgical Staplers</condition>
  <condition>Tissue Adhesives</condition>
  <condition>Chest Tubes</condition>
  <arm_group>
    <arm_group_label>FOREseal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Stapling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FOREseal</intervention_name>
    <description>a pair of alginate sleeves for linear cutting staplers used in lung surgery</description>
    <arm_group_label>FOREseal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stapling</intervention_name>
    <description>Stapling alon or associated with sealants</description>
    <arm_group_label>Stapling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient 18 years old or over.

          -  Patient that undergoes a lobectomy or bilobectomy for lung cancer,

          -  Patient presenting an incomplete fissure, requiring stapling of at least 50% of the
             fissure and/or an emphysematous lung at the fissure point, requiring stapling.

          -  Patient that has signed the informed consent before the operation.

          -  Patient that benefits from a social security regime.

        Exclusion Criteria:

          -  Patient with history of thoracotomy on the side operated on.

          -  Patient with severe pleural infection and/or infection of parenchyma.

          -  Presence of air leakage after liberation of lung in cases of pleural symphysis.

          -  Patient pregnant, giving birth or nursing.

          -  Patient presenting a contra indication to the aerostatic products used.

          -  Patient already participating in biomedical research.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean François REGNARD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Hotel Dieu</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Paris</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Fleisher AG, Evans KG, Nelems B, Finley RJ. Effect of routine fibrin glue use on the duration of air leaks after lobectomy. Ann Thorac Surg. 1990 Jan;49(1):133-4.</citation>
    <PMID>2297261</PMID>
  </reference>
  <reference>
    <citation>Macchiarini P, Wain J, Almy S, Dartevelle P. Experimental and clinical evaluation of a new synthetic, absorbable sealant to reduce air leaks in thoracic operations. J Thorac Cardiovasc Surg. 1999 Apr;117(4):751-8.</citation>
    <PMID>10096971</PMID>
  </reference>
  <reference>
    <citation>Porte HL, Jany T, Akkad R, Conti M, Gillet PA, Guidat A, Wurtz AJ. Randomized controlled trial of a synthetic sealant for preventing alveolar air leaks after lobectomy. Ann Thorac Surg. 2001 May;71(5):1618-22.</citation>
    <PMID>11383810</PMID>
  </reference>
  <reference>
    <citation>Wain JC, Kaiser LR, Johnstone DW, Yang SC, Wright CD, Friedberg JS, Feins RH, Heitmiller RF, Mathisen DJ, Selwyn MR. Trial of a novel synthetic sealant in preventing air leaks after lung resection. Ann Thorac Surg. 2001 May;71(5):1623-8; discussion 1628-9.</citation>
    <PMID>11383811</PMID>
  </reference>
  <reference>
    <citation>Fabian T, Federico JA, Ponn RB. Fibrin glue in pulmonary resection: a prospective, randomized, blinded study. Ann Thorac Surg. 2003 May;75(5):1587-92.</citation>
    <PMID>12735583</PMID>
  </reference>
  <reference>
    <citation>Thomas P, Massard G, Porte H, Doddoli C, Ducrocq X, Conti M. A new bioabsorbable sleeve for lung staple-line reinforcement (FOREseal): report of a three-center phase II clinical trial. Eur J Cardiothorac Surg. 2006 Jun;29(6):880-5. Epub 2006 May 3.</citation>
    <PMID>16675257</PMID>
  </reference>
  <reference>
    <citation>Abolhoda A, Liu D, Brooks A, Burt M. Prolonged air leak following radical upper lobectomy: an analysis of incidence and possible risk factors. Chest. 1998 Jun;113(6):1507-10.</citation>
    <PMID>9631785</PMID>
  </reference>
  <reference>
    <citation>Stéphan F, Boucheseiche S, Hollande J, Flahault A, Cheffi A, Bazelly B, Bonnet F. Pulmonary complications following lung resection: a comprehensive analysis of incidence and possible risk factors. Chest. 2000 Nov;118(5):1263-70.</citation>
    <PMID>11083673</PMID>
  </reference>
  <reference>
    <citation>Varela G, Jiménez MF, Novoa N, Aranda JL. Estimating hospital costs attributable to prolonged air leak in pulmonary lobectomy. Eur J Cardiothorac Surg. 2005 Feb;27(2):329-33.</citation>
    <PMID>15691691</PMID>
  </reference>
  <reference>
    <citation>Mouritzen C, Drömer M, Keinecke HO. The effect of fibrin glueing to seal bronchial and alveolar leakages after pulmonary resections and decortications. Eur J Cardiothorac Surg. 1993;7(2):75-80.</citation>
    <PMID>8442983</PMID>
  </reference>
  <reference>
    <citation>Wong K, Goldstraw P. Effect of fibrin glue in the reduction of postthoracotomy alveolar air leak. Ann Thorac Surg. 1997 Oct;64(4):979-81.</citation>
    <PMID>9354513</PMID>
  </reference>
  <reference>
    <citation>Tansley P, Al-Mulhim F, Lim E, Ladas G, Goldstraw P. A prospective, randomized, controlled trial of the effectiveness of BioGlue in treating alveolar air leaks. J Thorac Cardiovasc Surg. 2006 Jul;132(1):105-12.</citation>
    <PMID>16798309</PMID>
  </reference>
  <reference>
    <citation>Rami R, Mateu M. Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer. Cochrane Database Syst Rev. 2001;(4):CD003051. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003051.</citation>
    <PMID>11687173</PMID>
  </reference>
  <reference>
    <citation>Belboul A, Dernevik L, Aljassim O, Skrbic B, Rådberg G, Roberts D. The effect of autologous fibrin sealant (Vivostat) on morbidity after pulmonary lobectomy: a prospective randomised, blinded study. Eur J Cardiothorac Surg. 2004 Dec;26(6):1187-91.</citation>
    <PMID>15541982</PMID>
  </reference>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2009</study_first_submitted>
  <study_first_submitted_qc>June 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2009</study_first_posted>
  <last_update_submitted>September 17, 2013</last_update_submitted>
  <last_update_submitted_qc>September 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Absorbable implants</keyword>
  <keyword>Humans</keyword>
  <keyword>Alginates</keyword>
  <keyword>Pneumonectomy/methods</keyword>
  <keyword>Pneumonectomy/instrumentation</keyword>
  <keyword>Surgical Stapling</keyword>
  <keyword>Thoracic surgery</keyword>
  <keyword>Tissue Adhesives</keyword>
  <keyword>Prospective studies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

